nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.35	0.403	CrCrCtD
Dimenhydrinate—Orphenadrine—Tamoxifen—pancreatic cancer	0.275	0.316	CrCrCtD
Dimenhydrinate—Diphenhydramine—Tamoxifen—pancreatic cancer	0.244	0.281	CrCrCtD
Dimenhydrinate—Chest tightness—Docetaxel—pancreatic cancer	0.00213	0.0199	CcSEcCtD
Dimenhydrinate—Neuritis—Gemcitabine—pancreatic cancer	0.00189	0.0176	CcSEcCtD
Dimenhydrinate—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.00163	0.0152	CcSEcCtD
Dimenhydrinate—Nasal congestion—Sunitinib—pancreatic cancer	0.0014	0.0131	CcSEcCtD
Dimenhydrinate—Neuritis—Docetaxel—pancreatic cancer	0.00134	0.0125	CcSEcCtD
Dimenhydrinate—Euphoric mood—Fluorouracil—pancreatic cancer	0.00119	0.0111	CcSEcCtD
Dimenhydrinate—Photosensitivity—Fluorouracil—pancreatic cancer	0.00115	0.0107	CcSEcCtD
Dimenhydrinate—Chest discomfort—Docetaxel—pancreatic cancer	0.00113	0.0105	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.00111	0.0104	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000964	0.00898	CcSEcCtD
Dimenhydrinate—Irritability—Fluorouracil—pancreatic cancer	0.000961	0.00895	CcSEcCtD
Dimenhydrinate—Chills—Erlotinib—pancreatic cancer	0.000915	0.00853	CcSEcCtD
Dimenhydrinate—Neuritis—Epirubicin—pancreatic cancer	0.000904	0.00843	CcSEcCtD
Dimenhydrinate—Sweating increased—Irinotecan—pancreatic cancer	0.000885	0.00825	CcSEcCtD
Dimenhydrinate—Neuritis—Doxorubicin—pancreatic cancer	0.000837	0.0078	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000794	0.0074	CcSEcCtD
Dimenhydrinate—Chills—Sunitinib—pancreatic cancer	0.000792	0.00738	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000773	0.00721	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.00076	0.00709	CcSEcCtD
Dimenhydrinate—Dry mouth—Tamoxifen—pancreatic cancer	0.000747	0.00696	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000736	0.00686	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000724	0.00675	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000717	0.00668	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000709	0.00661	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000708	0.0066	CcSEcCtD
Dimenhydrinate—Anorexia—Tamoxifen—pancreatic cancer	0.000698	0.0065	CcSEcCtD
Dimenhydrinate—Anorexia—Erlotinib—pancreatic cancer	0.000691	0.00644	CcSEcCtD
Dimenhydrinate—Convulsion—Sunitinib—pancreatic cancer	0.000666	0.0062	CcSEcCtD
Dimenhydrinate—Insomnia—Tamoxifen—pancreatic cancer	0.000662	0.00617	CcSEcCtD
Dimenhydrinate—Paraesthesia—Tamoxifen—pancreatic cancer	0.000657	0.00613	CcSEcCtD
Dimenhydrinate—Insomnia—Erlotinib—pancreatic cancer	0.000655	0.00611	CcSEcCtD
Dimenhydrinate—Chills—Irinotecan—pancreatic cancer	0.000652	0.00608	CcSEcCtD
Dimenhydrinate—Dyspepsia—Tamoxifen—pancreatic cancer	0.000645	0.00601	CcSEcCtD
Dimenhydrinate—Dry mouth—Sunitinib—pancreatic cancer	0.00064	0.00596	CcSEcCtD
Dimenhydrinate—Dyspepsia—Erlotinib—pancreatic cancer	0.000638	0.00594	CcSEcCtD
Dimenhydrinate—Decreased appetite—Tamoxifen—pancreatic cancer	0.000636	0.00593	CcSEcCtD
Dimenhydrinate—Chills—Gemcitabine—pancreatic cancer	0.000636	0.00592	CcSEcCtD
Dimenhydrinate—Fatigue—Tamoxifen—pancreatic cancer	0.000631	0.00588	CcSEcCtD
Dimenhydrinate—Decreased appetite—Erlotinib—pancreatic cancer	0.00063	0.00587	CcSEcCtD
Dimenhydrinate—Constipation—Tamoxifen—pancreatic cancer	0.000626	0.00584	CcSEcCtD
Dimenhydrinate—Fatigue—Erlotinib—pancreatic cancer	0.000625	0.00582	CcSEcCtD
Dimenhydrinate—Constipation—Erlotinib—pancreatic cancer	0.000619	0.00577	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000614	0.00572	CcSEcCtD
Dimenhydrinate—Anorexia—Sunitinib—pancreatic cancer	0.000598	0.00557	CcSEcCtD
Dimenhydrinate—Urticaria—Tamoxifen—pancreatic cancer	0.000582	0.00542	CcSEcCtD
Dimenhydrinate—Vision blurred—Fluorouracil—pancreatic cancer	0.000571	0.00532	CcSEcCtD
Dimenhydrinate—Vertigo—Irinotecan—pancreatic cancer	0.000569	0.0053	CcSEcCtD
Dimenhydrinate—Insomnia—Sunitinib—pancreatic cancer	0.000567	0.00529	CcSEcCtD
Dimenhydrinate—Paraesthesia—Sunitinib—pancreatic cancer	0.000563	0.00525	CcSEcCtD
Dimenhydrinate—Photosensitivity—Epirubicin—pancreatic cancer	0.000558	0.0052	CcSEcCtD
Dimenhydrinate—Dyspepsia—Sunitinib—pancreatic cancer	0.000552	0.00514	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000549	0.00512	CcSEcCtD
Dimenhydrinate—Decreased appetite—Sunitinib—pancreatic cancer	0.000545	0.00508	CcSEcCtD
Dimenhydrinate—Fatigue—Sunitinib—pancreatic cancer	0.000541	0.00504	CcSEcCtD
Dimenhydrinate—Constipation—Sunitinib—pancreatic cancer	0.000536	0.005	CcSEcCtD
Dimenhydrinate—Asthenia—Tamoxifen—pancreatic cancer	0.000525	0.0049	CcSEcCtD
Dimenhydrinate—Convulsion—Fluorouracil—pancreatic cancer	0.000525	0.0049	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Docetaxel—pancreatic cancer	0.000522	0.00487	CcSEcCtD
Dimenhydrinate—Confusional state—Irinotecan—pancreatic cancer	0.000521	0.00485	CcSEcCtD
Dimenhydrinate—Asthenia—Erlotinib—pancreatic cancer	0.00052	0.00484	CcSEcCtD
Dimenhydrinate—Photosensitivity—Doxorubicin—pancreatic cancer	0.000516	0.00481	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000506	0.00471	CcSEcCtD
Dimenhydrinate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000501	0.00467	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000499	0.00465	CcSEcCtD
Dimenhydrinate—Confusional state—Fluorouracil—pancreatic cancer	0.000499	0.00465	CcSEcCtD
Dimenhydrinate—Diarrhoea—Erlotinib—pancreatic cancer	0.000496	0.00462	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000493	0.00459	CcSEcCtD
Dimenhydrinate—Anorexia—Irinotecan—pancreatic cancer	0.000492	0.00459	CcSEcCtD
Dimenhydrinate—Diplopia—Epirubicin—pancreatic cancer	0.00049	0.00457	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000486	0.00453	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000484	0.00451	CcSEcCtD
Dimenhydrinate—Dizziness—Tamoxifen—pancreatic cancer	0.000484	0.00451	CcSEcCtD
Dimenhydrinate—Tachycardia—Fluorouracil—pancreatic cancer	0.000483	0.0045	CcSEcCtD
Dimenhydrinate—Hypotension—Irinotecan—pancreatic cancer	0.000483	0.0045	CcSEcCtD
Dimenhydrinate—Anorexia—Gemcitabine—pancreatic cancer	0.00048	0.00447	CcSEcCtD
Dimenhydrinate—Dizziness—Erlotinib—pancreatic cancer	0.000479	0.00446	CcSEcCtD
Dimenhydrinate—Anorexia—Fluorouracil—pancreatic cancer	0.000472	0.0044	CcSEcCtD
Dimenhydrinate—Hypotension—Gemcitabine—pancreatic cancer	0.00047	0.00438	CcSEcCtD
Dimenhydrinate—Insomnia—Irinotecan—pancreatic cancer	0.000467	0.00435	CcSEcCtD
Dimenhydrinate—Vomiting—Tamoxifen—pancreatic cancer	0.000466	0.00434	CcSEcCtD
Dimenhydrinate—Paraesthesia—Irinotecan—pancreatic cancer	0.000464	0.00432	CcSEcCtD
Dimenhydrinate—Hypotension—Fluorouracil—pancreatic cancer	0.000462	0.00431	CcSEcCtD
Dimenhydrinate—Rash—Tamoxifen—pancreatic cancer	0.000462	0.0043	CcSEcCtD
Dimenhydrinate—Dermatitis—Tamoxifen—pancreatic cancer	0.000461	0.0043	CcSEcCtD
Dimenhydrinate—Vomiting—Erlotinib—pancreatic cancer	0.000461	0.00429	CcSEcCtD
Dimenhydrinate—Somnolence—Irinotecan—pancreatic cancer	0.000459	0.00428	CcSEcCtD
Dimenhydrinate—Headache—Tamoxifen—pancreatic cancer	0.000459	0.00428	CcSEcCtD
Dimenhydrinate—Rash—Erlotinib—pancreatic cancer	0.000457	0.00426	CcSEcCtD
Dimenhydrinate—Dermatitis—Erlotinib—pancreatic cancer	0.000456	0.00425	CcSEcCtD
Dimenhydrinate—Insomnia—Gemcitabine—pancreatic cancer	0.000455	0.00424	CcSEcCtD
Dimenhydrinate—Dyspepsia—Irinotecan—pancreatic cancer	0.000455	0.00424	CcSEcCtD
Dimenhydrinate—Headache—Erlotinib—pancreatic cancer	0.000454	0.00423	CcSEcCtD
Dimenhydrinate—Diplopia—Doxorubicin—pancreatic cancer	0.000453	0.00423	CcSEcCtD
Dimenhydrinate—Paraesthesia—Gemcitabine—pancreatic cancer	0.000452	0.00421	CcSEcCtD
Dimenhydrinate—Chills—Docetaxel—pancreatic cancer	0.000451	0.0042	CcSEcCtD
Dimenhydrinate—Asthenia—Sunitinib—pancreatic cancer	0.00045	0.00419	CcSEcCtD
Dimenhydrinate—Decreased appetite—Irinotecan—pancreatic cancer	0.000449	0.00419	CcSEcCtD
Dimenhydrinate—Insomnia—Fluorouracil—pancreatic cancer	0.000447	0.00417	CcSEcCtD
Dimenhydrinate—Somnolence—Gemcitabine—pancreatic cancer	0.000447	0.00417	CcSEcCtD
Dimenhydrinate—Fatigue—Irinotecan—pancreatic cancer	0.000445	0.00415	CcSEcCtD
Dimenhydrinate—Paraesthesia—Fluorouracil—pancreatic cancer	0.000444	0.00414	CcSEcCtD
Dimenhydrinate—Constipation—Irinotecan—pancreatic cancer	0.000442	0.00412	CcSEcCtD
Dimenhydrinate—Somnolence—Fluorouracil—pancreatic cancer	0.00044	0.0041	CcSEcCtD
Dimenhydrinate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000437	0.00408	CcSEcCtD
Dimenhydrinate—Dyspepsia—Fluorouracil—pancreatic cancer	0.000436	0.00406	CcSEcCtD
Dimenhydrinate—Nausea—Tamoxifen—pancreatic cancer	0.000435	0.00405	CcSEcCtD
Dimenhydrinate—Fatigue—Gemcitabine—pancreatic cancer	0.000434	0.00404	CcSEcCtD
Dimenhydrinate—Constipation—Gemcitabine—pancreatic cancer	0.00043	0.00401	CcSEcCtD
Dimenhydrinate—Nausea—Erlotinib—pancreatic cancer	0.00043	0.00401	CcSEcCtD
Dimenhydrinate—Decreased appetite—Fluorouracil—pancreatic cancer	0.00043	0.00401	CcSEcCtD
Dimenhydrinate—Diarrhoea—Sunitinib—pancreatic cancer	0.000429	0.004	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000426	0.00397	CcSEcCtD
Dimenhydrinate—Dizziness—Sunitinib—pancreatic cancer	0.000415	0.00387	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000415	0.00386	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000408	0.0038	CcSEcCtD
Dimenhydrinate—Vomiting—Sunitinib—pancreatic cancer	0.000399	0.00372	CcSEcCtD
Dimenhydrinate—Dysuria—Epirubicin—pancreatic cancer	0.000396	0.00369	CcSEcCtD
Dimenhydrinate—Rash—Sunitinib—pancreatic cancer	0.000395	0.00369	CcSEcCtD
Dimenhydrinate—Dermatitis—Sunitinib—pancreatic cancer	0.000395	0.00368	CcSEcCtD
Dimenhydrinate—Urticaria—Fluorouracil—pancreatic cancer	0.000393	0.00366	CcSEcCtD
Dimenhydrinate—Headache—Sunitinib—pancreatic cancer	0.000393	0.00366	CcSEcCtD
Dimenhydrinate—Pollakiuria—Epirubicin—pancreatic cancer	0.000391	0.00365	CcSEcCtD
Dimenhydrinate—Palpitations—Docetaxel—pancreatic cancer	0.000387	0.0036	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000387	0.0036	CcSEcCtD
Dimenhydrinate—Convulsion—Docetaxel—pancreatic cancer	0.000379	0.00353	CcSEcCtD
Dimenhydrinate—Drowsiness—Epirubicin—pancreatic cancer	0.000378	0.00352	CcSEcCtD
Dimenhydrinate—Nausea—Sunitinib—pancreatic cancer	0.000372	0.00347	CcSEcCtD
Dimenhydrinate—Asthenia—Irinotecan—pancreatic cancer	0.000371	0.00345	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00037	0.00345	CcSEcCtD
Dimenhydrinate—Dysuria—Doxorubicin—pancreatic cancer	0.000366	0.00342	CcSEcCtD
Dimenhydrinate—Dry mouth—Docetaxel—pancreatic cancer	0.000364	0.0034	CcSEcCtD
Dimenhydrinate—Pollakiuria—Doxorubicin—pancreatic cancer	0.000362	0.00337	CcSEcCtD
Dimenhydrinate—Asthenia—Gemcitabine—pancreatic cancer	0.000361	0.00336	CcSEcCtD
Dimenhydrinate—Confusional state—Docetaxel—pancreatic cancer	0.00036	0.00336	CcSEcCtD
Dimenhydrinate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000358	0.00333	CcSEcCtD
Dimenhydrinate—Diarrhoea—Irinotecan—pancreatic cancer	0.000353	0.00329	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000352	0.00328	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00035	0.00326	CcSEcCtD
Dimenhydrinate—Drowsiness—Doxorubicin—pancreatic cancer	0.000349	0.00326	CcSEcCtD
Dimenhydrinate—Tachycardia—Docetaxel—pancreatic cancer	0.000349	0.00325	CcSEcCtD
Dimenhydrinate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000344	0.00321	CcSEcCtD
Dimenhydrinate—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000343	0.00319	CcSEcCtD
Dimenhydrinate—Dizziness—Irinotecan—pancreatic cancer	0.000342	0.00318	CcSEcCtD
Dimenhydrinate—Anorexia—Docetaxel—pancreatic cancer	0.00034	0.00317	CcSEcCtD
Dimenhydrinate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000339	0.00315	CcSEcCtD
Dimenhydrinate—Hypotension—Docetaxel—pancreatic cancer	0.000334	0.00311	CcSEcCtD
Dimenhydrinate—Vomiting—Irinotecan—pancreatic cancer	0.000328	0.00306	CcSEcCtD
Dimenhydrinate—Dizziness—Fluorouracil—pancreatic cancer	0.000327	0.00305	CcSEcCtD
Dimenhydrinate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000326	0.00304	CcSEcCtD
Dimenhydrinate—Rash—Irinotecan—pancreatic cancer	0.000326	0.00304	CcSEcCtD
Dimenhydrinate—Dermatitis—Irinotecan—pancreatic cancer	0.000325	0.00303	CcSEcCtD
Dimenhydrinate—Headache—Irinotecan—pancreatic cancer	0.000324	0.00302	CcSEcCtD
Dimenhydrinate—Insomnia—Docetaxel—pancreatic cancer	0.000323	0.00301	CcSEcCtD
Dimenhydrinate—Paraesthesia—Docetaxel—pancreatic cancer	0.000321	0.00299	CcSEcCtD
Dimenhydrinate—Vomiting—Gemcitabine—pancreatic cancer	0.00032	0.00298	CcSEcCtD
Dimenhydrinate—Somnolence—Docetaxel—pancreatic cancer	0.000317	0.00296	CcSEcCtD
Dimenhydrinate—Rash—Gemcitabine—pancreatic cancer	0.000317	0.00296	CcSEcCtD
Dimenhydrinate—Dermatitis—Gemcitabine—pancreatic cancer	0.000317	0.00295	CcSEcCtD
Dimenhydrinate—Tinnitus—Epirubicin—pancreatic cancer	0.000316	0.00295	CcSEcCtD
Dimenhydrinate—Headache—Gemcitabine—pancreatic cancer	0.000315	0.00294	CcSEcCtD
Dimenhydrinate—Vomiting—Fluorouracil—pancreatic cancer	0.000315	0.00293	CcSEcCtD
Dimenhydrinate—Dyspepsia—Docetaxel—pancreatic cancer	0.000314	0.00293	CcSEcCtD
Dimenhydrinate—Rash—Fluorouracil—pancreatic cancer	0.000312	0.00291	CcSEcCtD
Dimenhydrinate—Dermatitis—Fluorouracil—pancreatic cancer	0.000312	0.0029	CcSEcCtD
Dimenhydrinate—Decreased appetite—Docetaxel—pancreatic cancer	0.00031	0.00289	CcSEcCtD
Dimenhydrinate—Headache—Fluorouracil—pancreatic cancer	0.00031	0.00289	CcSEcCtD
Dimenhydrinate—Fatigue—Docetaxel—pancreatic cancer	0.000308	0.00287	CcSEcCtD
Dimenhydrinate—Nausea—Irinotecan—pancreatic cancer	0.000307	0.00286	CcSEcCtD
Dimenhydrinate—Constipation—Docetaxel—pancreatic cancer	0.000305	0.00285	CcSEcCtD
Dimenhydrinate—Chills—Epirubicin—pancreatic cancer	0.000304	0.00284	CcSEcCtD
Dimenhydrinate—Nausea—Gemcitabine—pancreatic cancer	0.000299	0.00279	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000294	0.00274	CcSEcCtD
Dimenhydrinate—Nausea—Fluorouracil—pancreatic cancer	0.000294	0.00274	CcSEcCtD
Dimenhydrinate—Tinnitus—Doxorubicin—pancreatic cancer	0.000292	0.00273	CcSEcCtD
Dimenhydrinate—Tension—Epirubicin—pancreatic cancer	0.00029	0.0027	CcSEcCtD
Dimenhydrinate—Nervousness—Epirubicin—pancreatic cancer	0.000287	0.00267	CcSEcCtD
Dimenhydrinate—Chills—Doxorubicin—pancreatic cancer	0.000281	0.00262	CcSEcCtD
Dimenhydrinate—Vision blurred—Epirubicin—pancreatic cancer	0.000278	0.00259	CcSEcCtD
Dimenhydrinate—Agitation—Epirubicin—pancreatic cancer	0.000271	0.00253	CcSEcCtD
Dimenhydrinate—Tension—Doxorubicin—pancreatic cancer	0.000268	0.0025	CcSEcCtD
Dimenhydrinate—Nervousness—Doxorubicin—pancreatic cancer	0.000265	0.00247	CcSEcCtD
Dimenhydrinate—Vertigo—Epirubicin—pancreatic cancer	0.000265	0.00247	CcSEcCtD
Dimenhydrinate—Palpitations—Epirubicin—pancreatic cancer	0.000261	0.00243	CcSEcCtD
Dimenhydrinate—Vision blurred—Doxorubicin—pancreatic cancer	0.000257	0.0024	CcSEcCtD
Dimenhydrinate—Asthenia—Docetaxel—pancreatic cancer	0.000256	0.00239	CcSEcCtD
Dimenhydrinate—Convulsion—Epirubicin—pancreatic cancer	0.000256	0.00238	CcSEcCtD
Dimenhydrinate—Agitation—Doxorubicin—pancreatic cancer	0.000251	0.00234	CcSEcCtD
Dimenhydrinate—Dry mouth—Epirubicin—pancreatic cancer	0.000246	0.00229	CcSEcCtD
Dimenhydrinate—Vertigo—Doxorubicin—pancreatic cancer	0.000245	0.00229	CcSEcCtD
Dimenhydrinate—Diarrhoea—Docetaxel—pancreatic cancer	0.000244	0.00228	CcSEcCtD
Dimenhydrinate—Confusional state—Epirubicin—pancreatic cancer	0.000243	0.00226	CcSEcCtD
Dimenhydrinate—Palpitations—Doxorubicin—pancreatic cancer	0.000241	0.00225	CcSEcCtD
Dimenhydrinate—Convulsion—Doxorubicin—pancreatic cancer	0.000237	0.00221	CcSEcCtD
Dimenhydrinate—Dizziness—Docetaxel—pancreatic cancer	0.000236	0.0022	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000236	0.0022	CcSEcCtD
Dimenhydrinate—Tachycardia—Epirubicin—pancreatic cancer	0.000235	0.00219	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000233	0.00217	CcSEcCtD
Dimenhydrinate—Anorexia—Epirubicin—pancreatic cancer	0.00023	0.00214	CcSEcCtD
Dimenhydrinate—Dry mouth—Doxorubicin—pancreatic cancer	0.000227	0.00212	CcSEcCtD
Dimenhydrinate—Vomiting—Docetaxel—pancreatic cancer	0.000227	0.00212	CcSEcCtD
Dimenhydrinate—Rash—Docetaxel—pancreatic cancer	0.000225	0.0021	CcSEcCtD
Dimenhydrinate—Hypotension—Epirubicin—pancreatic cancer	0.000225	0.0021	CcSEcCtD
Dimenhydrinate—Dermatitis—Docetaxel—pancreatic cancer	0.000225	0.0021	CcSEcCtD
Dimenhydrinate—Confusional state—Doxorubicin—pancreatic cancer	0.000225	0.00209	CcSEcCtD
Dimenhydrinate—Headache—Docetaxel—pancreatic cancer	0.000224	0.00208	CcSEcCtD
Dimenhydrinate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000218	0.00203	CcSEcCtD
Dimenhydrinate—Insomnia—Epirubicin—pancreatic cancer	0.000218	0.00203	CcSEcCtD
Dimenhydrinate—Tachycardia—Doxorubicin—pancreatic cancer	0.000218	0.00203	CcSEcCtD
Dimenhydrinate—Paraesthesia—Epirubicin—pancreatic cancer	0.000216	0.00202	CcSEcCtD
Dimenhydrinate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000215	0.00201	CcSEcCtD
Dimenhydrinate—Somnolence—Epirubicin—pancreatic cancer	0.000214	0.002	CcSEcCtD
Dimenhydrinate—Anorexia—Doxorubicin—pancreatic cancer	0.000212	0.00198	CcSEcCtD
Dimenhydrinate—Nausea—Docetaxel—pancreatic cancer	0.000212	0.00198	CcSEcCtD
Dimenhydrinate—Dyspepsia—Epirubicin—pancreatic cancer	0.000212	0.00198	CcSEcCtD
Dimenhydrinate—Decreased appetite—Epirubicin—pancreatic cancer	0.000209	0.00195	CcSEcCtD
Dimenhydrinate—Hypotension—Doxorubicin—pancreatic cancer	0.000208	0.00194	CcSEcCtD
Dimenhydrinate—Fatigue—Epirubicin—pancreatic cancer	0.000208	0.00194	CcSEcCtD
Dimenhydrinate—Constipation—Epirubicin—pancreatic cancer	0.000206	0.00192	CcSEcCtD
Dimenhydrinate—Insomnia—Doxorubicin—pancreatic cancer	0.000202	0.00188	CcSEcCtD
Dimenhydrinate—Paraesthesia—Doxorubicin—pancreatic cancer	0.0002	0.00187	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000198	0.00185	CcSEcCtD
Dimenhydrinate—Somnolence—Doxorubicin—pancreatic cancer	0.000198	0.00185	CcSEcCtD
Dimenhydrinate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000196	0.00183	CcSEcCtD
Dimenhydrinate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000194	0.00181	CcSEcCtD
Dimenhydrinate—Fatigue—Doxorubicin—pancreatic cancer	0.000192	0.00179	CcSEcCtD
Dimenhydrinate—Urticaria—Epirubicin—pancreatic cancer	0.000191	0.00178	CcSEcCtD
Dimenhydrinate—Constipation—Doxorubicin—pancreatic cancer	0.000191	0.00178	CcSEcCtD
Dimenhydrinate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000184	0.00171	CcSEcCtD
Dimenhydrinate—Urticaria—Doxorubicin—pancreatic cancer	0.000177	0.00165	CcSEcCtD
Dimenhydrinate—Asthenia—Epirubicin—pancreatic cancer	0.000173	0.00161	CcSEcCtD
Dimenhydrinate—Diarrhoea—Epirubicin—pancreatic cancer	0.000165	0.00154	CcSEcCtD
Dimenhydrinate—Asthenia—Doxorubicin—pancreatic cancer	0.00016	0.00149	CcSEcCtD
Dimenhydrinate—Dizziness—Epirubicin—pancreatic cancer	0.000159	0.00148	CcSEcCtD
Dimenhydrinate—Vomiting—Epirubicin—pancreatic cancer	0.000153	0.00143	CcSEcCtD
Dimenhydrinate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000152	0.00142	CcSEcCtD
Dimenhydrinate—Rash—Epirubicin—pancreatic cancer	0.000152	0.00142	CcSEcCtD
Dimenhydrinate—Dermatitis—Epirubicin—pancreatic cancer	0.000152	0.00141	CcSEcCtD
Dimenhydrinate—Headache—Epirubicin—pancreatic cancer	0.000151	0.00141	CcSEcCtD
Dimenhydrinate—Dizziness—Doxorubicin—pancreatic cancer	0.000147	0.00137	CcSEcCtD
Dimenhydrinate—Nausea—Epirubicin—pancreatic cancer	0.000143	0.00133	CcSEcCtD
Dimenhydrinate—Vomiting—Doxorubicin—pancreatic cancer	0.000142	0.00132	CcSEcCtD
Dimenhydrinate—Rash—Doxorubicin—pancreatic cancer	0.000141	0.00131	CcSEcCtD
Dimenhydrinate—Dermatitis—Doxorubicin—pancreatic cancer	0.00014	0.00131	CcSEcCtD
Dimenhydrinate—Headache—Doxorubicin—pancreatic cancer	0.00014	0.0013	CcSEcCtD
Dimenhydrinate—Nausea—Doxorubicin—pancreatic cancer	0.000132	0.00123	CcSEcCtD
Dimenhydrinate—HRH1—Signaling by GPCR—SSTR1—pancreatic cancer	6.04e-05	0.00265	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—CNR1—pancreatic cancer	5.95e-05	0.00261	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SSTR1—pancreatic cancer	5.94e-05	0.0026	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PPY—pancreatic cancer	5.92e-05	0.0026	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—CNR1—pancreatic cancer	5.85e-05	0.00257	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PPY—pancreatic cancer	5.83e-05	0.00255	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—SSTR2—pancreatic cancer	5.81e-05	0.00255	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—GCG—pancreatic cancer	5.75e-05	0.00252	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SSTR2—pancreatic cancer	5.72e-05	0.00251	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	5.66e-05	0.00248	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—GCG—pancreatic cancer	5.65e-05	0.00248	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCKBR—pancreatic cancer	5.61e-05	0.00246	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCKBR—pancreatic cancer	5.52e-05	0.00242	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	5.48e-05	0.0024	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	5.42e-05	0.00238	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—AGTR1—pancreatic cancer	5.39e-05	0.00236	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	5.31e-05	0.00233	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GAST—pancreatic cancer	5.23e-05	0.00229	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	5.23e-05	0.00229	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	5.04e-05	0.00221	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—SCT—pancreatic cancer	4.96e-05	0.00217	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GAST—pancreatic cancer	4.83e-05	0.00212	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	4.81e-05	0.00211	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GAST—pancreatic cancer	4.75e-05	0.00208	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CCK—pancreatic cancer	4.73e-05	0.00207	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—NRAS—pancreatic cancer	4.71e-05	0.00207	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	4.68e-05	0.00205	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	4.68e-05	0.00205	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GLP1R—pancreatic cancer	4.61e-05	0.00202	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CNR2—pancreatic cancer	4.61e-05	0.00202	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	4.61e-05	0.00202	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.6e-05	0.00202	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—SCT—pancreatic cancer	4.58e-05	0.00201	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CCKAR—pancreatic cancer	4.53e-05	0.00199	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SCT—pancreatic cancer	4.5e-05	0.00197	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	4.37e-05	0.00192	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCK—pancreatic cancer	4.36e-05	0.00191	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PRLHR—pancreatic cancer	4.3e-05	0.00189	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCK—pancreatic cancer	4.29e-05	0.00188	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—pancreatic cancer	4.29e-05	0.00188	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	4.25e-05	0.00187	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	4.25e-05	0.00187	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CNR2—pancreatic cancer	4.19e-05	0.00184	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GLP1R—pancreatic cancer	4.19e-05	0.00184	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	4.18e-05	0.00183	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	4.15e-05	0.00182	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CCKAR—pancreatic cancer	4.12e-05	0.00181	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	4.11e-05	0.0018	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	4.11e-05	0.0018	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—IAPP—pancreatic cancer	4.08e-05	0.00179	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—CXCL8—pancreatic cancer	4.08e-05	0.00179	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—pancreatic cancer	4.06e-05	0.00178	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ZNRF3—pancreatic cancer	4.05e-05	0.00177	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ACVR1B—pancreatic cancer	4.05e-05	0.00177	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	3.98e-05	0.00175	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.94e-05	0.00173	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PTHLH—pancreatic cancer	3.92e-05	0.00172	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—SHH—pancreatic cancer	3.82e-05	0.00167	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	3.77e-05	0.00165	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SHH—pancreatic cancer	3.75e-05	0.00165	CbGpPWpGaD
Dimenhydrinate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—pancreatic cancer	3.73e-05	0.00163	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DTX1—pancreatic cancer	3.72e-05	0.00163	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	3.72e-05	0.00163	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—IAPP—pancreatic cancer	3.71e-05	0.00163	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DTX1—pancreatic cancer	3.66e-05	0.0016	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SSTR3—pancreatic cancer	3.66e-05	0.0016	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—SST—pancreatic cancer	3.64e-05	0.0016	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	3.62e-05	0.00159	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	3.62e-05	0.00159	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—SST—pancreatic cancer	3.58e-05	0.00157	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	3.57e-05	0.00157	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	3.57e-05	0.00156	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PTHLH—pancreatic cancer	3.56e-05	0.00156	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PTCH1—pancreatic cancer	3.56e-05	0.00156	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SSTR1—pancreatic cancer	3.51e-05	0.00154	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PPY—pancreatic cancer	3.5e-05	0.00153	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PPY—pancreatic cancer	3.44e-05	0.00151	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	3.43e-05	0.00151	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SSTR2—pancreatic cancer	3.38e-05	0.00148	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	3.36e-05	0.00147	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	3.32e-05	0.00145	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—SST—pancreatic cancer	3.31e-05	0.00145	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CNR1—pancreatic cancer	3.31e-05	0.00145	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.3e-05	0.00145	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCKBR—pancreatic cancer	3.26e-05	0.00143	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	3.26e-05	0.00143	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—SST—pancreatic cancer	3.25e-05	0.00143	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	3.25e-05	0.00142	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.24e-05	0.00142	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GCG—pancreatic cancer	3.19e-05	0.0014	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	3.16e-05	0.00138	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DTX4—pancreatic cancer	3.12e-05	0.00137	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GLI1—pancreatic cancer	3.12e-05	0.00137	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	3.1e-05	0.00136	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	3.08e-05	0.00135	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DTX4—pancreatic cancer	3.07e-05	0.00134	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GLI1—pancreatic cancer	3.07e-05	0.00134	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	3.05e-05	0.00134	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AGTR1—pancreatic cancer	3.05e-05	0.00134	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	3.03e-05	0.00133	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRP1—pancreatic cancer	3.03e-05	0.00133	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CNR1—pancreatic cancer	3e-05	0.00132	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRP1—pancreatic cancer	2.98e-05	0.00131	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PPP2R5B—pancreatic cancer	2.98e-05	0.00131	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GCG—pancreatic cancer	2.95e-05	0.00129	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HEY2—pancreatic cancer	2.92e-05	0.00128	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GCG—pancreatic cancer	2.9e-05	0.00127	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HEY2—pancreatic cancer	2.87e-05	0.00126	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GAST—pancreatic cancer	2.85e-05	0.00125	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	2.83e-05	0.00124	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	2.81e-05	0.00123	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GAST—pancreatic cancer	2.81e-05	0.00123	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AGTR1—pancreatic cancer	2.77e-05	0.00121	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SCT—pancreatic cancer	2.7e-05	0.00119	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HEY1—pancreatic cancer	2.7e-05	0.00119	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SCT—pancreatic cancer	2.66e-05	0.00117	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HEY1—pancreatic cancer	2.66e-05	0.00117	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.61e-05	0.00115	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCK—pancreatic cancer	2.58e-05	0.00113	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCK—pancreatic cancer	2.54e-05	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	2.51e-05	0.0011	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CNR2—pancreatic cancer	2.51e-05	0.0011	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	2.51e-05	0.0011	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GLP1R—pancreatic cancer	2.47e-05	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CNR2—pancreatic cancer	2.47e-05	0.00108	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	2.47e-05	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—CXCL8—pancreatic cancer	2.47e-05	0.00108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCKAR—pancreatic cancer	2.43e-05	0.00107	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JAG2—pancreatic cancer	2.4e-05	0.00105	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MEN1—pancreatic cancer	2.36e-05	0.00104	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAG2—pancreatic cancer	2.36e-05	0.00103	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MEN1—pancreatic cancer	2.32e-05	0.00102	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SHH—pancreatic cancer	2.25e-05	0.000988	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	2.24e-05	0.000982	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—IAPP—pancreatic cancer	2.23e-05	0.000976	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SHH—pancreatic cancer	2.22e-05	0.000972	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH4—pancreatic cancer	2.2e-05	0.000966	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—IAPP—pancreatic cancer	2.19e-05	0.00096	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	2.14e-05	0.000937	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	2.14e-05	0.000937	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTHLH—pancreatic cancer	2.1e-05	0.000922	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	2.1e-05	0.000922	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SST—pancreatic cancer	1.95e-05	0.000857	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.93e-05	0.000845	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SST—pancreatic cancer	1.92e-05	0.000843	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—JAG1—pancreatic cancer	1.91e-05	0.000838	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	1.9e-05	0.000835	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.9e-05	0.000831	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	1.88e-05	0.000825	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	1.87e-05	0.000822	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CNR1—pancreatic cancer	1.8e-05	0.000791	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	1.77e-05	0.000778	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.75e-05	0.000767	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GCG—pancreatic cancer	1.74e-05	0.000764	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.72e-05	0.000755	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GCG—pancreatic cancer	1.71e-05	0.000751	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.69e-05	0.000743	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.67e-05	0.000731	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	1.66e-05	0.000729	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STK11—pancreatic cancer	1.64e-05	0.000718	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	1.63e-05	0.000717	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STK11—pancreatic cancer	1.61e-05	0.000706	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.54e-05	0.000675	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.51e-05	0.000664	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.48e-05	0.000648	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.45e-05	0.000637	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	1.43e-05	0.000629	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.42e-05	0.000622	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	1.41e-05	0.000619	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HES1—pancreatic cancer	1.4e-05	0.000614	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.4e-05	0.000612	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HES1—pancreatic cancer	1.38e-05	0.000604	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.34e-05	0.000588	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.32e-05	0.000579	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	1.29e-05	0.000565	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	1.27e-05	0.000556	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TERT—pancreatic cancer	1.23e-05	0.000538	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TERT—pancreatic cancer	1.21e-05	0.000529	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.17e-05	0.000515	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.17e-05	0.000513	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	1.15e-05	0.000506	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	1.15e-05	0.000505	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.15e-05	0.000502	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—APOE—pancreatic cancer	1.13e-05	0.000494	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.12e-05	0.000492	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KDR—pancreatic cancer	1.1e-05	0.000484	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	1.07e-05	0.000468	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	1.06e-05	0.000464	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	1.05e-05	0.000461	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	1.04e-05	0.000456	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	1.03e-05	0.000453	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	1.03e-05	0.000453	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.02e-05	0.000448	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	1.02e-05	0.000446	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	1.02e-05	0.000446	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGF—pancreatic cancer	1.01e-05	0.000441	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	9.42e-06	0.000413	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	9.27e-06	0.000406	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	9.09e-06	0.000399	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	9e-06	0.000395	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	8.94e-06	0.000392	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	8.9e-06	0.00039	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.86e-06	0.000388	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	8.76e-06	0.000384	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	8.18e-06	0.000358	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	8.04e-06	0.000353	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	7.92e-06	0.000347	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	7.8e-06	0.000342	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	7.61e-06	0.000334	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	7.56e-06	0.000332	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	7.49e-06	0.000328	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	7.44e-06	0.000326	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	7.35e-06	0.000322	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CASP3—pancreatic cancer	7.29e-06	0.000319	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	7.24e-06	0.000317	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	7.17e-06	0.000314	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CCND1—pancreatic cancer	7.09e-06	0.000311	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	7.02e-06	0.000308	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	6.98e-06	0.000306	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	6.91e-06	0.000303	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MMP9—pancreatic cancer	6.89e-06	0.000302	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PTEN—pancreatic cancer	6.85e-06	0.0003	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	6.78e-06	0.000297	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	6.74e-06	0.000295	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	6.68e-06	0.000293	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	6.57e-06	0.000288	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—SRC—pancreatic cancer	6.35e-06	0.000278	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—SRC—pancreatic cancer	6.25e-06	0.000274	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	6.18e-06	0.000271	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STAT3—pancreatic cancer	6.12e-06	0.000268	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—NRAS—pancreatic cancer	6.11e-06	0.000268	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	6.08e-06	0.000267	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	6.02e-06	0.000264	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	6.01e-06	0.000263	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—MYC—pancreatic cancer	5.69e-06	0.000249	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	5.68e-06	0.000249	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—MYC—pancreatic cancer	5.6e-06	0.000245	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	5.58e-06	0.000245	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EGFR—pancreatic cancer	5.56e-06	0.000244	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	5.48e-06	0.00024	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—KRAS—pancreatic cancer	5.26e-06	0.00023	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	5.17e-06	0.000227	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	4.83e-06	0.000212	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	4.75e-06	0.000208	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.67e-06	0.000205	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—TP53—pancreatic cancer	4.6e-06	0.000202	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRAS—pancreatic cancer	4.47e-06	0.000196	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	4.4e-06	0.000193	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.95e-06	0.000173	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	3.88e-06	0.00017	CbGpPWpGaD
